ClinConnect ClinConnect Logo
Search / Trial NCT06511583

FBS-ASaP: Fibrobronchoscopy in ASpiration Pneumonia in the Emergency Department

Launched by AZIENDA OSPEDALIERO-UNIVERSITARIA CAREGGI · Jul 15, 2024

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

Aspiration Pneumonia Bronchoscopy Toilette Interventional Pulmunology Respiratory Failure Pneumonia Bacterial Pneumonia

ClinConnect Summary

The FBS-ASaP trial is a study designed to explore the best way to treat patients with aspiration pneumonia in the Emergency Department. Aspiration pneumonia occurs when food, liquid, or secretions enter the lungs, causing infection. This study will compare two methods of clearing these secretions: one using a special tube called a probe and the other using a more advanced technique called videobronchoscopy, which allows doctors to see inside the airways. By collecting data from patients who undergo these procedures, researchers hope to understand which method is more effective and if there are any risks associated with either approach.

To be eligible for this study, participants must be adults diagnosed with aspiration pneumonia and require help to clear secretions or ingesta. Some key criteria include having a confirmed diagnosis through imaging tests, showing signs of respiratory distress, or needing oxygen support. If you or someone you know is interested in participating, you can expect to be part of a registry that tracks your treatment and health outcomes over the study period. This research is important as it could lead to better treatment options for patients with aspiration pneumonia in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All adult patients who access the Emergency Department with a diagnosis of aspiration pneumonia and for whom the referring physician determines the need for aspiration of secretions or ingesta. Patients must have at least one of the following criteria
  • Radiological evidence of pneumonia (Chest X-ray/CT scan/Chest ultrasound)
  • Clinical diagnosis of aspiration pneumonia
  • Presence of secretions in the upper airways
  • Respiratory distress in a dysphagic patient
  • Need for oxygen therapy or need to increase FiO2 in patients already on home oxygen therapy
  • Exclusion Criteria:
  • Lack of consent
  • Age \< 18 years
  • Pregnancy
  • Hemorrhagic diathesis
  • Malignant cardiac arrhythmias (VT, AV block excluding first-degree AV block)
  • Severe airway obstruction

About Azienda Ospedaliero Universitaria Careggi

Azienda Ospedaliero-Universitaria Careggi is a leading healthcare institution in Italy, renowned for its integration of advanced clinical research and comprehensive patient care. Situated in Florence, it operates as both a hospital and a university facility, fostering a collaborative environment that bridges innovative medical research with academic excellence. The institution is committed to improving health outcomes through cutting-edge clinical trials and the development of new therapeutic strategies, supported by a multidisciplinary team of experts dedicated to advancing medical knowledge and enhancing patient well-being.

Locations

Florence, Tuscany/Italy, Italy

Florence, , Italy

Patients applied

0 patients applied

Trial Officials

Lorenzo Pelagatti, dr

Principal Investigator

University of Florence

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported